The pathway’s design is informed by research into discharge planning, multidisciplinary transitional care, home assessment, carer involvement and rehabilitation after hospitalisation. The studies below inform how care is connected and tailored.
Results vary by population, clinical condition and programme. This research does not establish that the Clinics GRP Hospital-to-Home service prevents readmissions or achieves the outcomes reported in these studies. Direct evidence for this pathway’s specific assistant-supported step-down model remains limited.
Australian clinical guidance
The Australian Commission on Safety and Quality in Health Care emphasises communication at transfers, agreed goals, patient and carer involvement, structured handover and continuity of medicines information. These are design references, not a claim of accreditation or endorsement.
Program and policy references
The government Transition Care Program and Restorative Care Pathway have separate eligibility and funding rules. These references explain program context, not this service’s effectiveness.
Clinics GRP Hospital-to-Home does not provide Hospital in the Home or replace hospital-level acute care. HITH research is not used here as evidence of this pathway’s efficacy.
Review status: Reviewed and approved by the Clinics GRP Clinical Review Team on 7 September 2026. This is an evidence-informed service description, not a validated clinical protocol.
Service evaluation is active. Clinical, functional and service measures are used to review the pathway. Active evaluation does not establish that the service reduces readmissions or achieves the outcomes reported in published studies.